| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.13e-19 | 114 | 172 | 19 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.12e-18 | 124 | 172 | 19 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.82e-18 | 137 | 172 | 19 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.69e-15 | 192 | 172 | 19 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 TMPRSS11E USP17L24 PIDD1 USP17L5 USP17L19 USP17L18 USP17L17 TLL2 TMPRSS11D USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.08e-08 | 654 | 172 | 23 | GO:0008233 |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 7.38e-05 | 2 | 172 | 2 | GO:0033872 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 7.26e-19 | 125 | 172 | 19 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.14e-17 | 144 | 172 | 19 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L7 USP17L21 ZSWIM8 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 MAGEF1 USP17L18 MED24 ARNT USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.16e-05 | 1009 | 172 | 23 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L7 USP17L21 ZSWIM8 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 MAGEF1 USP17L18 MED24 ARNT USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.11e-05 | 1074 | 172 | 23 | GO:0043687 |
| MousePheno | social withdrawal | 3.45e-05 | 21 | 127 | 4 | MP:0001361 | |
| MousePheno | increased trophectoderm apoptosis | 3.97e-05 | 8 | 127 | 3 | MP:0012119 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13 | 1.19e-27 | 16 | 165 | 14 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13 | 1.19e-27 | 16 | 165 | 14 | IPR006861 |
| Domain | UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 8.65e-22 | 71 | 165 | 18 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 8.65e-22 | 71 | 165 | 18 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.14e-21 | 72 | 165 | 18 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.14e-21 | 72 | 165 | 18 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 1.14e-21 | 72 | 165 | 18 | IPR001394 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 9.08e-21 | 66 | 165 | 17 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13 | 2.76e-20 | 70 | 165 | 17 | PS00972 |
| Domain | MAP6 | 7.76e-05 | 2 | 165 | 2 | IPR007882 | |
| Domain | KIND | 2.31e-04 | 3 | 165 | 2 | PF16474 | |
| Domain | KIND_dom | 7.62e-04 | 5 | 165 | 2 | IPR011019 | |
| Domain | KIND | 7.62e-04 | 5 | 165 | 2 | SM00750 | |
| Domain | KIND | 7.62e-04 | 5 | 165 | 2 | PS51377 | |
| Domain | Pept_S1A_HAT/DESC1 | 7.62e-04 | 5 | 165 | 2 | IPR017329 | |
| Domain | VWFA | 7.99e-04 | 82 | 165 | 5 | PS50234 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.14e-24 | 45 | 117 | 17 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L5 USP17L19 AXIN2 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.42e-15 | 191 | 117 | 19 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 AXIN2 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.11e-14 | 221 | 117 | 19 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L5 USP17L19 AXIN2 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.61e-13 | 262 | 117 | 19 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L24 USP17L5 USP17L19 AXIN2 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.82e-12 | 299 | 117 | 19 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 DLG3 USP17L22 IL17RD USP17L15 USP17L8 USP17L13 | 1.42e-11 | 318 | 117 | 19 | MM15278 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.48e-04 | 61 | 117 | 5 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.32e-04 | 67 | 117 | 5 | M26999 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.36e-04 | 15 | 117 | 3 | M27161 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 VGF USP17L21 COL7A1 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP11 USP17L11 USP17L5 USP17L19 ANO8 AXIN2 USP17L18 USP17L17 MDC1 USP17L3 USP17L22 USP17L15 TP53BP1 USP17L8 USP17L13 | 3.90e-04 | 1389 | 117 | 24 | MM15307 |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.18e-04 | 76 | 117 | 5 | MM14573 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.36e-36 | 21 | 179 | 17 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.36e-36 | 21 | 179 | 17 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.36e-36 | 21 | 179 | 17 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.36e-36 | 21 | 179 | 17 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.36e-36 | 21 | 179 | 17 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 3.36e-36 | 21 | 179 | 17 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.47e-35 | 22 | 179 | 17 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.92e-34 | 24 | 179 | 17 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.97e-34 | 25 | 179 | 17 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.72e-33 | 26 | 179 | 17 | 35816173 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.59e-33 | 33 | 179 | 18 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 20403174 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 20388806 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 14699124 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.47e-33 | 34 | 179 | 18 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.12e-32 | 35 | 179 | 18 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.12e-32 | 35 | 179 | 18 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.23e-32 | 36 | 179 | 18 | 20147298 | |
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.81e-32 | 29 | 179 | 17 | 32527007 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.33e-32 | 37 | 179 | 18 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 4.87e-27 | 50 | 179 | 17 | 31806660 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 1.01e-14 | 10 | 179 | 7 | 24207026 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L7 USP17L4 USP17L2 USP17L1 USP11 USP17L3 USP17L15 USP17L8 | 3.03e-14 | 19 | 179 | 8 | 28067227 |
| Pubmed | 6.59e-14 | 12 | 179 | 7 | 24695638 | ||
| Pubmed | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 MATN1 ZNF185 USP17L5 ARHGAP30 USP17L19 USP17L18 NUTM1 MBLAC1 SALL1 USP17L17 USP17L3 USP17L22 USP17L15 TMEM40 USP17L8 USP17L13 | 1.19e-13 | 674 | 179 | 24 | 37196079 | |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 2.83e-13 | 14 | 179 | 7 | 11793228 | |
| Pubmed | USP17L7 USP17L4 USP17L2 USP17L1 USP11 USP17L3 USP17L15 USP17L8 | 9.83e-09 | 81 | 179 | 8 | 12838346 | |
| Pubmed | 1.75e-07 | 48 | 179 | 6 | 16421571 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L20 CT47A1 USP17L11 USP17L19 USP17L18 USP17L17 | 2.03e-07 | 119 | 179 | 8 | 28625976 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPIRE2 ANKS6 GTPBP6 MFHAS1 POLE ARFGEF2 ICE1 SRCAP ARHGEF11 ZBTB42 ANO8 RADIL TNRC18 CELSR2 TRAPPC12 CPSF1 TNKS1BP1 IL17RD DOCK6 CEP170B SOWAHB | 2.94e-07 | 1105 | 179 | 21 | 35748872 |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | 5.34e-07 | 4 | 179 | 3 | 22984479 | |
| Pubmed | VGF GPRASP1 CACNA1E DMXL2 ZNF219 HCN4 MAP6 APC2 DDN DIDO1 ARMCX4 PPFIA3 LMTK3 ARHGEF11 SF3B1 CELSR2 DLG3 CEP170B TP53BP1 | 6.43e-07 | 963 | 179 | 19 | 28671696 | |
| Pubmed | CACNA1E DMXL2 PACSIN3 LMTK3 ELFN2 PITPNM1 RADIL SLC4A10 TNKS1BP1 CEP170B GABBR1 | 2.08e-06 | 347 | 179 | 11 | 17114649 | |
| Pubmed | GPRASP1 DMXL2 HCN4 MAP6 PPFIA3 ELFN2 NACAD ANO8 PITPNM1 RALY TNRC18 SF3B1 CELSR2 SLC4A10 KNDC1 DLG3 CEP170B GABBR1 TP53BP1 | 7.34e-06 | 1139 | 179 | 19 | 36417873 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 7.93e-06 | 91 | 179 | 6 | 20362542 | |
| Pubmed | NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. | 1.09e-05 | 27 | 179 | 4 | 23359859 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 DLG5 RBM15 USP11 BCORL1 SRCAP ARNT SALL1 TCERG1 CPNE3 TNKS1BP1 CEP170B TP53BP1 | 1.25e-05 | 588 | 179 | 13 | 38580884 |
| Pubmed | Spatiotemporal regulation of GLI target genes in the mammalian limb bud. | 1.29e-05 | 207 | 179 | 8 | 26238476 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17546051 | ||
| Pubmed | The in vivo dynamic interplay of MDC1 and 53BP1 at DNA damage-induced nuclear foci. | 2.63e-05 | 2 | 179 | 2 | 22677490 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 27426949 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 18158901 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 10698202 | ||
| Pubmed | A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. | 2.63e-05 | 2 | 179 | 2 | 10520990 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 15304505 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 22475533 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17884766 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 18986980 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 8167223 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 17525268 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 16009723 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11259252 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 31511635 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 25976740 | ||
| Pubmed | 3.00e-05 | 233 | 179 | 8 | 37704626 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DLG5 RBM15 DMXL2 USP17L1 RRP1B MAP6 DIDO1 LMTK3 SRCAP THOC6 RALY SF3B1 TCERG1 CPNE3 CPSF1 TNKS1BP1 DOCK6 | 4.80e-05 | 1082 | 179 | 17 | 38697112 |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 5.66e-05 | 79 | 179 | 5 | 18757743 | |
| Pubmed | 7.26e-05 | 340 | 179 | 9 | 24332808 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 28554271 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 28397142 | ||
| Pubmed | Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis. | 7.88e-05 | 3 | 179 | 2 | 18504301 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 14695167 | ||
| Pubmed | Assignment of a locus for autosomal dominant idiopathic scoliosis (IS) to human chromosome 17p11. | 7.88e-05 | 3 | 179 | 2 | 12384783 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 22860035 | ||
| Pubmed | Human X chromosome exome sequencing identifies BCORL1 as contributor to spermatogenesis. | 7.88e-05 | 3 | 179 | 2 | 32376790 | |
| Pubmed | RNF168 ubiquitylates 53BP1 and controls its response to DNA double-strand breaks. | 7.88e-05 | 3 | 179 | 2 | 24324146 | |
| Pubmed | Tyrosine kinase c-Abl couples RNA polymerase II transcription to DNA double-strand breaks. | 7.88e-05 | 3 | 179 | 2 | 30668775 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 20421415 | ||
| Pubmed | Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor. | 7.88e-05 | 3 | 179 | 2 | 10021369 | |
| Pubmed | NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway. | 7.88e-05 | 3 | 179 | 2 | 19001859 | |
| Pubmed | 1.02e-04 | 47 | 179 | 4 | 15172686 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.17e-04 | 283 | 179 | 8 | 30585729 | |
| Pubmed | 1.22e-04 | 19 | 179 | 3 | 23616926 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | USP17L7 USP17L12 BCORL1 PIDD1 ARHGAP9 ICE1 PPFIA3 ARHGEF17 ERLEC1 USP17L3 CPSF1 PLCB3 PLXNB3 | 1.23e-04 | 736 | 179 | 13 | 29676528 |
| Pubmed | DMXL2 STRBP POLE DIDO1 GIGYF1 ARNT TCERG1 AP5B1 CPNE3 LRCH4 PLCB3 SLC33A1 | 1.50e-04 | 650 | 179 | 12 | 38777146 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.52e-04 | 220 | 179 | 7 | 35785414 | |
| Pubmed | ZSWIM8 RBM15 RRP1B USP11 STRBP POLE DIDO1 SF3B1 MDC1 CPSF1 TNKS1BP1 TP53BP1 | 1.57e-04 | 653 | 179 | 12 | 22586326 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 29976755 | ||
| Pubmed | MCPH1 functions in an H2AX-dependent but MDC1-independent pathway in response to DNA damage. | 1.57e-04 | 4 | 179 | 2 | 17925396 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 7744762 | ||
| Pubmed | A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. | 1.57e-04 | 4 | 179 | 2 | 16901786 | |
| Pubmed | Replication independent ATR signalling leads to G2/M arrest requiring Nbs1, 53BP1 and MDC1. | 1.57e-04 | 4 | 179 | 2 | 18664457 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 9988768 | ||
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 16837464 | ||
| Pubmed | MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. | 1.57e-04 | 4 | 179 | 2 | 21293379 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 12551934 | ||
| Pubmed | DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. | 1.57e-04 | 4 | 179 | 2 | 12556884 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RBM15 ARFGEF2 DIDO1 PITPNM1 TUBGCP6 MED24 SF3B1 MTAP MDC1 CPSF1 TNKS1BP1 PLCB3 TP53BP1 | 2.01e-04 | 774 | 179 | 13 | 15302935 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.05e-04 | 231 | 179 | 7 | 16452087 | |
| Pubmed | 2.08e-04 | 104 | 179 | 5 | 9205841 | ||
| Pubmed | 2.38e-04 | 107 | 179 | 5 | 11347906 | ||
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 32017326 | ||
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 3.47e-16 | 79 | 179 | 12 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L20 FAM53A USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 5.45e-12 | 222 | 179 | 13 | chr4p16 |
| Cytoband | 8p23.1 | USP17L7 USP17L4 USP17L2 USP17L1 MFHAS1 SPAG11A SPAG11B USP17L3 USP17L8 | 1.11e-08 | 154 | 179 | 9 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | USP17L7 USP17L4 USP17L2 USP17L1 MFHAS1 SPAG11A SPAG11B USP17L3 USP17L8 | 3.98e-07 | 234 | 179 | 9 | chr8p23 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 4.41e-04 | 454 | 179 | 8 | chr11q13 | |
| Cytoband | 5p15.3 | 6.66e-04 | 10 | 179 | 2 | 5p15.3 | |
| Cytoband | 20p11.2 | 8.12e-04 | 11 | 179 | 2 | 20p11.2 | |
| GeneFamily | PDZ domain containing | 2.22e-04 | 152 | 102 | 6 | 1220 | |
| GeneFamily | Copines | 1.11e-03 | 9 | 102 | 2 | 829 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 1.11e-03 | 9 | 102 | 2 | 90 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.83e-03 | 43 | 102 | 3 | 409 | |
| GeneFamily | Collagens | 2.22e-03 | 46 | 102 | 3 | 490 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 INSRR USP17L5 USP17L19 USP17L18 MED24 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.75e-21 | 112 | 177 | 19 | MM1095 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 1.53e-20 | 86 | 177 | 17 | MM1312 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 8.62e-16 | 160 | 177 | 17 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 ZNF185 USP17L5 USP17L19 USP17L18 PITPNM1 COL18A1 USP17L17 USP17L3 USP17L22 SLC33A1 USP17L15 TMEM40 USP17L8 USP17L13 | 5.50e-10 | 647 | 177 | 22 | MM981 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 RBM15 USP17L4 ZNF219 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 ZNF185 USP17L5 USP17L19 USP17L18 PITPNM1 COL18A1 CELSR2 USP17L17 USP17L3 PLCB3 USP17L22 SLC33A1 USP17L15 TMEM40 USP17L8 USP17L13 | 2.30e-07 | 1226 | 177 | 26 | MM979 |
| Coexpression | PEREZ_TP53_TARGETS | WHRN ABHD15 DLG5 MAP6 MFHAS1 MAP6D1 APC2 ARFGEF2 PIDD1 DIDO1 ZSWIM6 ARHGEF17 ZBTB42 ELFN2 TUBGCP6 COL18A1 BICDL1 CELSR2 KNDC1 HS3ST3B1 CEP170B TMEM40 DOC2B | 6.68e-06 | 1201 | 177 | 23 | M4391 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 P4HA3 USP17L19 PTGR3 SIX6 USP17L18 USP17L17 USP17L3 CD72 USP17L22 USP17L15 USP17L8 USP17L13 | 1.24e-05 | 1072 | 177 | 21 | MM1031 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L7 COL4A2 WHRN USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 C20orf144 SVEP1 USP17L18 MTAP USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 2.06e-05 | 1198 | 177 | 22 | MM1062 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_200 | 1.46e-05 | 42 | 158 | 5 | gudmap_developingKidney_e15.5_S-shaped body_200_k4 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 1.54e-05 | 148 | 158 | 8 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#3_top-relative-expression-ranked_1000 | NDNF PSD2 STRBP FAM53A DIDO1 IRX3 ERLEC1 PITPNM1 TCF23 HS3ST3B1 | 3.26e-05 | 267 | 158 | 10 | gudmap_developingKidney_e12.5_renal vesicle_1000_k3 |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 150 | 171 | 7 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-06 | 163 | 171 | 7 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 171 | 171 | 7 | c60313b045cb77c0923ddb81bbd1a654aa1087c5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-06 | 174 | 171 | 7 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 175 | 171 | 7 | db6be3e9e339918418fcaf9001ea15207aa6c993 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 175 | 171 | 7 | 8acac10c9eedccebcf3a3fe31bfee35afa54579f | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-06 | 175 | 171 | 7 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.23e-06 | 175 | 171 | 7 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-06 | 175 | 171 | 7 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 177 | 171 | 7 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 177 | 171 | 7 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | COVID-19_Mild-dn_T|COVID-19_Mild / Disease condition and Cell class | 5.80e-06 | 116 | 171 | 6 | 79c918f3bebfd5e0b865d2c7673af9ee3bc48779 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-06 | 180 | 171 | 7 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 183 | 171 | 7 | 797eb968c57e48db33ff8e2236ee22e9425c4676 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.27e-06 | 184 | 171 | 7 | 3e9d75af578297950e469f23fb2d28393a2feef8 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 185 | 171 | 7 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.66e-06 | 189 | 171 | 7 | 78dcda09109a5cfb04ba069f16ec80987b3ad432 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 9.92e-06 | 193 | 171 | 7 | 7c14bc481ed38378b9e6a85f768a1e526c5997e6 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 194 | 171 | 7 | 6a4e7f1bf67bad94cd8c472e7c66798b0c25ba01 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-05 | 195 | 171 | 7 | 69201b1172bcf0999c726516e4d30863afceab0b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 196 | 171 | 7 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 171 | 7 | fe22833e69928a1478df265e1c356c463611dedd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-QPCT|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | 85e1b598c9f3976215b20eeda077d8aab621cce6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-QPCT-L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | 2f2c5331511a924fa0bb1689f4c81641d754c9b9 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 140 | 171 | 6 | a8f3b01d03ee0bf0e752327a98d6b9035930c2b0 | |
| ToppCell | P07-Hematopoietic-Immune-immune_cell_unspecified|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.99e-05 | 144 | 171 | 6 | eb057dbdb2a5a2d29b93e5ed5479a3fd1bf3fd26 | |
| ToppCell | P07-Hematopoietic-Immune|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.99e-05 | 144 | 171 | 6 | 962698c5c15bd583fccda0593b7aab5f2eb4bc9f | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-05 | 146 | 171 | 6 | bb7bf20245d93c8812920dd0debbf1ed00add378 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-05 | 158 | 171 | 6 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 3.48e-05 | 159 | 171 | 6 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-05 | 160 | 171 | 6 | 5c931e859acf67c1c8664941e0e44d195f8ba75b | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-05 | 168 | 171 | 6 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.74e-05 | 168 | 171 | 6 | 6c758eb120faf06ff72d157b495e399191c79ec9 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-05 | 168 | 171 | 6 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 169 | 171 | 6 | 2d23b4cee060f8adddc430c1c10d4e25205b4af6 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 169 | 171 | 6 | ecaf08e8e0b54d1c97a02bc1f65409fd43d68227 | |
| ToppCell | facs-Lung-Endomucin-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 169 | 171 | 6 | ad6af6609acf158cb79e45ee7ca9af332be3c40c | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Trm_gut_CD8|Lung / Manually curated celltypes from each tissue | 5.23e-05 | 171 | 171 | 6 | c8ccb7795ce8321739e3bc07db2ffc183d04e660 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.23e-05 | 171 | 171 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 172 | 171 | 6 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.58e-05 | 173 | 171 | 6 | 0a355386210a13927ea29b10b64cb059459952d4 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.58e-05 | 173 | 171 | 6 | 3678b300cad4effd7f49bfb043305ed512693848 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 174 | 171 | 6 | aae7ab9df5a78716034ddfd5bd47adc69912d624 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 174 | 171 | 6 | d9489c4196d103ead8cb6279492bbe563a222e45 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.94e-05 | 175 | 171 | 6 | 3bdccb4037053795d62ab5b6fcc09cdd406f9b50 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.94e-05 | 175 | 171 | 6 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.94e-05 | 175 | 171 | 6 | 770546ddaa49ee482c4c7577ab76efbc6c304a29 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.08e-05 | 108 | 171 | 5 | ba83418023d9d296b0edd4c4e1832a33bc9b3b69 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.08e-05 | 108 | 171 | 5 | a93a427ab16628c86db3bb17bfecf801f56ce270 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.08e-05 | 108 | 171 | 5 | 673da75b24218557d01ee461a13c426040da74b9 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-05 | 176 | 171 | 6 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.13e-05 | 176 | 171 | 6 | e2b59a904c5c8f9c88e1e63788e9b6485f22edd0 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.13e-05 | 176 | 171 | 6 | f931192e3cc65414e2245354f443473696cc7ce8 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.33e-05 | 177 | 171 | 6 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.33e-05 | 177 | 171 | 6 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-05 | 178 | 171 | 6 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 178 | 171 | 6 | 5ac5257d88fa0dc67714881d6f005f6cea925710 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-05 | 178 | 171 | 6 | 0b59e3d75b143bd7bf91a7800a49699c51e68c5a | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-05 | 179 | 171 | 6 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-05 | 179 | 171 | 6 | ec1d7017da325647b629de703135a404bbdc627d | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-05 | 179 | 171 | 6 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 180 | 171 | 6 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 180 | 171 | 6 | 0153667e44fdbc3c0d444dcb023069925a2b69a2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 180 | 171 | 6 | 40a28b410f46215d6d7cf8a02a18078eb046b5b0 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 180 | 171 | 6 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 180 | 171 | 6 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.38e-05 | 182 | 171 | 6 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 7.61e-05 | 183 | 171 | 6 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 183 | 171 | 6 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-05 | 183 | 171 | 6 | d4a558bc0b8e11be195a7da1468ab38eb477117d | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.84e-05 | 184 | 171 | 6 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.32e-05 | 186 | 171 | 6 | 064b6047215597465bb51a8a1547ef5a226552f9 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.32e-05 | 186 | 171 | 6 | 428b4cbee3d3ab666cab2fc2d9c815318359e458 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.32e-05 | 186 | 171 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 8.57e-05 | 187 | 171 | 6 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 187 | 171 | 6 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 187 | 171 | 6 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 187 | 171 | 6 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.82e-05 | 188 | 171 | 6 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 8.82e-05 | 188 | 171 | 6 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.82e-05 | 188 | 171 | 6 | c9270517e6940e9793586f67f02431210552f278 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-dn_T|COVID-19_Mild / Disease group, lineage and cell class | 8.89e-05 | 117 | 171 | 5 | 9d417dd137c27f8fe9e57842cd5515fdc2f2dc06 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.89e-05 | 117 | 171 | 5 | e74dd01ccb6cc630759146655fccec359f725b1d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.89e-05 | 117 | 171 | 5 | 3c67e8a184b5a8302cba584e5ee97006f6cd267f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.25e-05 | 118 | 171 | 5 | d95344ef24a1a838232186c02725f556c5fd51ac | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.25e-05 | 118 | 171 | 5 | c234ea1969726356ee47d9364b716044cfbd125a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.35e-05 | 190 | 171 | 6 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.63e-05 | 191 | 171 | 6 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.63e-05 | 191 | 171 | 6 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.91e-05 | 192 | 171 | 6 | 42fed1a4c88e62dffda026503e5da1eb21fe877f | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_T_Cells|Distal / Age, Tissue, Lineage and Cell class | 9.91e-05 | 192 | 171 | 6 | 7538c7f63108f357478ea4c5bf27c1f9825b87c7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 193 | 171 | 6 | d8e6a7f1da4506acaa06380b4aec3fe299ec8b7e | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.05e-04 | 194 | 171 | 6 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 15-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 1.08e-04 | 195 | 171 | 6 | ec392fc8bd2c0f1e3a79f2e401608fd6ba8d339c | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 196 | 171 | 6 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-04 | 196 | 171 | 6 | 072e0e29be4639344ead4ea6ad521e3338f5f8af | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-04 | 196 | 171 | 6 | d9426eba69047166ffa8179f1654e011c1020328 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-04 | 196 | 171 | 6 | 7e19919eafd6ddf547dd4e8aa532a050e182c5cc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 196 | 171 | 6 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 196 | 171 | 6 | bebb20dc210576101c317011e3afb59798f5d255 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.93e-29 | 46 | 172 | 18 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 ADCY2 AXIN2 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 USP17L8 USP17L13 | 5.95e-29 | 69 | 172 | 20 | DOID:1682 (implicated_via_orthology) |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | MFHAS1 TMPRSS11E NFE2L3 LRFN2 CELSR2 PLCB3 RFLNA DOCK6 TP53BP1 | 3.54e-05 | 274 | 172 | 9 | EFO_0004530, EFO_0004612 |
| Disease | hepatoblastoma (is_marker_for) | 8.41e-05 | 15 | 172 | 3 | DOID:687 (is_marker_for) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.92e-04 | 49 | 172 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.86e-04 | 153 | 172 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | cholesterol to total lipids in large HDL percentage | 3.02e-04 | 55 | 172 | 4 | EFO_0022234 | |
| Disease | Adenoid Cystic Carcinoma | 3.06e-04 | 100 | 172 | 5 | C0010606 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 3.95e-04 | 59 | 172 | 4 | EFO_0022248 | |
| Disease | disease recurrence, malaria | 9.24e-04 | 8 | 172 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.17e-03 | 200 | 172 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | Williams-Beuren syndrome (is_implicated_in) | 1.18e-03 | 9 | 172 | 2 | DOID:1928 (is_implicated_in) | |
| Disease | dietary approaches to stop hypertension diet | 1.18e-03 | 9 | 172 | 2 | EFO_0803365 | |
| Disease | apolipoprotein B measurement | COL4A2 ABHD15 TMPRSS11E GIGYF1 NFE2L3 TCF23 CELSR2 ZFHX3 PLCB3 RFLNA DOCK6 | 1.84e-03 | 663 | 172 | 11 | EFO_0004615 |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.90e-03 | 150 | 172 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.98e-03 | 222 | 172 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.08e-03 | 303 | 172 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.12e-03 | 225 | 172 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | IGF-1 measurement | DNAJC30 TMPRSS11E INSM1 SRCAP MED24 TCF23 SALL1 IL17RD DOCK6 | 2.36e-03 | 488 | 172 | 9 | EFO_0004627 |
| Disease | disorder of pharynx | 2.46e-03 | 46 | 172 | 3 | MONDO_0020592 | |
| Disease | smoking status measurement, carotid artery intima media thickness | 2.78e-03 | 48 | 172 | 3 | EFO_0006527, EFO_0007117 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.95e-03 | 166 | 172 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.10e-03 | 243 | 172 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | response to cisplatin | 3.30e-03 | 51 | 172 | 3 | GO_0072718 | |
| Disease | testosterone measurement | COL4A2 ZNF219 TMPRSS11E BCORL1 RMI2 ARHGAP9 SRCAP ZBTB42 ARNT TEX264 TRAPPC12 KNDC1 ZBTB10 PALM3 ZFHX3 TNKS1BP1 | 3.32e-03 | 1275 | 172 | 16 | EFO_0004908 |
| Disease | infant head circumference | 3.37e-03 | 15 | 172 | 2 | EFO_0004577 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.68e-03 | 53 | 172 | 3 | C4707243 | |
| Disease | Cardiovascular Abnormalities | 3.84e-03 | 16 | 172 | 2 | C0243050 | |
| Disease | triiodothyronine measurement | 3.84e-03 | 16 | 172 | 2 | EFO_0008392 | |
| Disease | Small cell carcinoma of lung | 3.88e-03 | 54 | 172 | 3 | C0149925 | |
| Disease | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy | 3.88e-03 | 54 | 172 | 3 | EFO_0000180, EFO_0003100, GO_0061479 | |
| Disease | Antithrombotic agent use measurement | 4.09e-03 | 55 | 172 | 3 | EFO_0009925 | |
| Disease | fatty acid measurement | 4.20e-03 | 436 | 172 | 8 | EFO_0005110 | |
| Disease | Benign neoplasm of stomach | 4.34e-03 | 17 | 172 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.34e-03 | 17 | 172 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 4.34e-03 | 17 | 172 | 2 | C0154060 | |
| Disease | cognitive function measurement | COL4A2 CACNA1E DMXL2 DDN FAM161B ARHGAP9 ZSWIM6 ADCY2 LRFN2 CPNE3 TMPRSS11D SLC4A10 CRYBG1 MYO18B HS3ST3B1 SOWAHB CPNE7 | 4.41e-03 | 1434 | 172 | 17 | EFO_0008354 |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 4.52e-03 | 57 | 172 | 3 | EFO_0022284 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 4.64e-03 | 264 | 172 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | cognitive behavioural therapy | 4.75e-03 | 58 | 172 | 3 | EFO_0007820 | |
| Disease | disease free survival | 4.86e-03 | 18 | 172 | 2 | EFO_0000409 | |
| Disease | triglycerides to total lipids in small LDL percentage | 4.98e-03 | 59 | 172 | 3 | EFO_0022337 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 5.22e-03 | 60 | 172 | 3 | EFO_0020690 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.58e-03 | 121 | 172 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 5.58e-03 | 121 | 172 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 5.74e-03 | 276 | 172 | 6 | EFO_0004612, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDSGFLPGRDCRDLE | 136 | O60347 | |
| RLRLEGPGDEDADGA | 171 | O60347 | |
| DSAGREGDREALLGD | 41 | O00400 | |
| IKRRPGLDFDDDGEG | 41 | P27540 | |
| EASGGGRALPQLSDD | 26 | Q96DZ1 | |
| RGSGLAGGLDEADTP | 991 | Q15878 | |
| ELGARGEEAAGGDRL | 61 | O43598 | |
| RPSRGEELGGAEGDT | 1141 | Q6F5E8 | |
| LSDLQGRAEGDPGVS | 1616 | Q5H9F3 | |
| ENGDAPRERGSSLSG | 266 | Q9Y6D5 | |
| RPSEGRLSLDSQEGD | 206 | O15085 | |
| LSIGDGDQRRGLPGE | 391 | P08572 | |
| FLDGDGGSLRSPLGE | 466 | O75131 | |
| RRNEDGLGEPEGRAS | 56 | Q9Y2T1 | |
| ISSRLGQDPGADDDG | 21 | P21854 | |
| GSSEHEDGEREGSPR | 461 | Q8TDJ6 | |
| LRAGERSPEESLGGR | 156 | Q9HCU4 | |
| ASLRAIDPDEGEAGR | 201 | Q9HCU4 | |
| DTEAADGERGSLGNP | 1136 | Q9Y4F5 | |
| APGDARADAGEDRVG | 346 | Q96NY7 | |
| AEGGRPGDSTLEERT | 531 | O94850 | |
| SAGRGDEPSIAEGKR | 551 | Q6ZP65 | |
| TPAEALLDSRVDGRG | 556 | Q5H9R4 | |
| RTLPGAQDRDDGEEA | 36 | Q6UXT9 | |
| GREEARAEGSGLDPA | 926 | Q9HCE9 | |
| AGLPQGEARTRDDGD | 266 | Q9UKM9 | |
| EESGGRHLDRSPESD | 646 | Q96T37 | |
| GGTGLDDPEILEGRT | 16 | Q13126 | |
| ISLLRDGDSGGPELS | 486 | Q9Y5P8 | |
| GGGAALDEDLERARS | 311 | P78413 | |
| LAAGPGEEELLRGSA | 106 | O60393 | |
| LGTGDPERAAARGDT | 16 | Q7Z4N8 | |
| VAGRERGDESPLGAE | 366 | A6NDB9 | |
| DLGRDSPIDRLLGEG | 886 | Q9HCL0 | |
| RDSAGDRAGDAPGEA | 206 | O95907 | |
| RGPRERKEDGSADGD | 336 | O75427 | |
| GSPAAADGRLSLGDR | 1011 | Q96JH8 | |
| APRLDDGSAGTRDGG | 91 | Q96PE2 | |
| GTSRALRDGGFEPEK | 441 | Q96PE2 | |
| GESDGRRTSQEGPGD | 511 | Q9NSK0 | |
| GLAAVPRGGSAEEDS | 71 | Q5JQC4 | |
| LRVAEAGGEASSPRD | 66 | O60496 | |
| GLDQDGEARPALDGS | 626 | Q8NFM7 | |
| SGERLISDPAGELGR | 296 | Q9Y662 | |
| LLDDSRGGEGLRDAA | 6 | Q9BYH8 | |
| AFGDAEGGRSRSPDI | 131 | P21941 | |
| ILERDTQRGEPEGGS | 941 | Q14676 | |
| LGAGREEGAAEPALT | 41 | Q9HAY2 | |
| TGPEAGRGRAAADAL | 271 | Q96JE9 | |
| RSIEEGDGAFGRSPR | 136 | O75420 | |
| EEVPEGLGSALGSLR | 76 | Q9Y4C4 | |
| GLRADGGRSRTGDDE | 56 | O43824 | |
| GTDRDGSVSLPGEAA | 21 | Q14695 | |
| GGDLPALDGARVDFR | 116 | Q9UBS5 | |
| EDGRRGSALGPDEAG | 11 | O75145 | |
| GSALGPDEAGGELER | 16 | O75145 | |
| GPGGDSNRRTAELEE | 226 | O75145 | |
| DSDDDLPRLGSSREG | 356 | Q8N3F9 | |
| DPGTDRTEDSGLAAG | 106 | Q96CP2 | |
| LAGDPAEVLGERGTA | 621 | Q96Q04 | |
| GARDELGGRSGPEAE | 716 | Q10570 | |
| GELRGLPATLEETAG | 726 | Q9ULL4 | |
| RLARGGSLEDEDTPE | 136 | A0A1W2PR82 | |
| LGDDGRTCVDSGRLP | 831 | P07202 | |
| SGSGLGDARELLREE | 666 | P39060 | |
| DPRAARSGPLDAGEE | 156 | Q9Y4A8 | |
| LSPGERRQLDEEAGG | 36 | Q8TDM6 | |
| SLQELPEDRSGEGSG | 91 | Q8TB73 | |
| GEELSGDGLVLPRAS | 31 | Q96MY7 | |
| RSRRSGAEDVGPEGE | 716 | Q8N9W4 | |
| SEELGPGRSGDTEDL | 1366 | Q96RT7 | |
| SGERLISDPAGELGR | 311 | Q9Y663 | |
| GPEGEDLGRDLLSDL | 26 | Q2VPB7 | |
| ESAEGVLRPGAIRDG | 1296 | Q07864 | |
| GPAAAADGGTVDLRE | 51 | Q9NX62 | |
| AEERRLIAEGDASPG | 126 | Q9Y3Q4 | |
| PSEGDGLGEEGLLSR | 506 | Q9UHF4 | |
| SGSVEDEDGDGRLRP | 496 | Q86Y26 | |
| RLRPGALGGAADVED | 1006 | Q01970 | |
| RIGGLAEEEASAGPR | 486 | P15863 | |
| SEEAAGGGDGLPRSR | 16 | Q08462 | |
| PAEGSRERGEEAAGS | 1661 | O95996 | |
| PEARSDAGRQTDGGE | 1346 | Q9Y2F5 | |
| GAGRRSPSDGAREDD | 66 | Q14184 | |
| DERSGPEDSNDSRRG | 161 | Q96HP0 | |
| TADRALGPRAGEELD | 66 | Q5SZD1 | |
| RDSASPDAGEGLGLR | 221 | Q6IN97 | |
| ARDTEGPRQGDLEAG | 86 | H7C350 | |
| QVLDGDDGVLRSPRG | 556 | Q9UBL6 | |
| GEGEGEPLSRLSARG | 1571 | Q9BTC0 | |
| AQGALPERDASRGGL | 1586 | Q9BTC0 | |
| GLGGSRDEPLDITAL | 181 | Q68DC2 | |
| AGGPADLSGELRRGD | 416 | Q92796 | |
| AAPRLRGAGEGSERE | 76 | Q9BQM9 | |
| RGTAGDADRELRGPS | 101 | Q7Z601 | |
| SPRGSGGAEAALEEA | 61 | A4D2B0 | |
| GGAEAALEEAARGPI | 66 | A4D2B0 | |
| LDSEEPGTGGAASRR | 36 | Q9H9H5 | |
| GLARGLEAGEESTPV | 996 | P14616 | |
| GEDRRPAGGASDVEA | 1051 | Q76NI1 | |
| DDPRTEFGLDALGSG | 86 | Q02388 | |
| SRELGRAAGAPGASD | 196 | Q9Y4K1 | |
| DRGLLSDEDLRGPGV | 111 | Q96LL9 | |
| AGADEGVRRSLSPEL | 611 | P15502 | |
| ATRNLGGLPEEAEGS | 601 | Q9NSC2 | |
| EDSDAGSRALPFLGG | 21 | Q9HB75 | |
| PVLGGFRESRAAEDG | 121 | Q9UKS6 | |
| GGRLDIREEAEGSPE | 666 | Q7Z6I6 | |
| RGGEDGDRALLLSPS | 21 | Q01101 | |
| RAEAREAPGGGSDRD | 336 | Q01101 | |
| PELSLAGAARRDGDL | 266 | P78415 | |
| RPRTDGERIGDSLFG | 456 | Q5JY77 | |
| GAEEAERGLSSGVLP | 221 | Q3SY00 | |
| LAEQLRRDAEGGPGA | 26 | Q96E14 | |
| RGRDDCGTFEDTGPL | 281 | Q14684 | |
| RPESALLGGSEAGER | 281 | O15240 | |
| EQRGSEAGPDARSLG | 691 | P48378 | |
| DGDGLILGEAPATLR | 151 | Q8IYJ0 | |
| RDSDTEGDLVLGSPG | 151 | Q14761 | |
| RLREGLEAGTPAAGE | 141 | O75448 | |
| SGRALRAEGDGTPEV | 201 | O95475 | |
| GSSALKRPFEDGLGD | 351 | Q96SI9 | |
| VDAGEAEASAPGRGR | 766 | Q9P202 | |
| ASGEEEEGDGTPRRR | 3176 | Q6ZRS2 | |
| SATEALGELRERAPG | 31 | Q08648 | |
| APGDEAAGSRVERLG | 51 | Q4LDE5 | |
| GASREREEGALAEPA | 236 | A6NEL2 | |
| ARGELDLERAPALGG | 56 | Q8N9L9 | |
| DSAAGNSEEREPRGL | 36 | B7Z368 | |
| APRDSEGLDGAGELG | 406 | O00562 | |
| GDSGGPLVQEDSRRL | 366 | O60235 | |
| GDSGGPLVSSDARDI | 371 | Q9UL52 | |
| ERPESAKAFGREGSG | 656 | O15417 | |
| SRGREPRALGAEDTD | 386 | A6NCW0 | |
| ERDSEGDSLGARPGL | 66 | Q8N8E2 | |
| PGSPRGSGREEDDEL | 41 | Q9Y548 | |
| SRGREPRALGAEDTD | 386 | A6NCW7 | |
| GDGGESERFNPGELR | 6 | O14776 | |
| PNSEGDAGDLGRVRD | 76 | Q8WVT3 | |
| GLVLDGTPEAEGRAR | 606 | Q96N76 | |
| AAGGDGELGSPLRRS | 211 | Q9BQI7 | |
| AETPRTDRGGDSIGE | 311 | O75533 | |
| LLRGDGSVGAREPEA | 66 | Q8WWL2 | |
| EQGREGLLDSPDSGL | 16 | Q6ZTI6 | |
| DRERDSGLEDGRESP | 76 | Q6U841 | |
| EDSLGEGSRDAGRPG | 1006 | Q9C0C2 | |
| GLRRRGSDPASGEVE | 131 | Q8WWA1 | |
| SRGREPRALGAEDTD | 386 | D6R9N7 | |
| SRGREPRALGAEDTD | 386 | A8MUK1 | |
| RGAGGLGERPDATAD | 21 | Q9Y6L7 | |
| LDLEGEGPLGESRLD | 276 | Q9Y6I9 | |
| SRGREPRALGAEDTD | 386 | D6R901 | |
| LRERSPEVLSGGEDG | 176 | Q86W42 | |
| SRGREPRALGAEDTD | 386 | C9JLJ4 | |
| SRGREPRALGAEDTD | 386 | D6RCP7 | |
| GDRENPLELRLSGSG | 456 | Q9BRR9 | |
| DVGAGALRRSDSPEI | 1451 | Q12888 | |
| SRGREPRALGAEDTD | 386 | Q7RTZ2 | |
| AVGALADGREDRGSP | 16 | A8MTW9 | |
| RAGDGAGALETELEG | 451 | Q8IUG5 | |
| EVDLGDLSPEGRFTG | 331 | Q8N4Q0 | |
| LGAGRLASEDELGPG | 276 | B2RXF5 | |
| SRGREPRALGAEDTD | 386 | C9JPN9 | |
| PGASRSGGLEESRDR | 516 | A7E2V4 | |
| AADGGDETRLPFRRG | 196 | Q9HCJ5 | |
| SRGREPRALGAEDTD | 386 | Q0WX57 | |
| SLLGAGDAGLRDVDP | 601 | Q16587 | |
| SRGREPRALGAEDTD | 386 | P0C7H9 | |
| SRGREPRALGAEDTD | 386 | P0C7I0 | |
| DLDGALLSGPDGDRN | 621 | Q96DT7 | |
| RAGGLALGRSEASPE | 66 | Q7RTU1 | |
| EDDGFGEAGDPRRLL | 56 | Q8N1Y9 | |
| SRGREPRALGAEDTD | 386 | D6RA61 | |
| SATEALGELRERAPG | 31 | Q6PDA7 | |
| SRGREPRALGAEDTD | 386 | C9J2P7 | |
| SRGREPRALGAEDTD | 386 | D6RBQ6 | |
| ENGESGRERPLRAGE | 86 | P51784 | |
| TEDSAGGGPETREAL | 1056 | Q96J92 | |
| GGGPETREALAESDR | 1061 | Q96J92 | |
| GSRPEGLAAVDIGSE | 356 | O15231 | |
| LRNGRGGEAEPLDLS | 616 | Q9P2Y4 | |
| SRGREPRALGAEDTD | 386 | Q6R6M4 | |
| SRGREPRALGAEDTD | 386 | D6RJB6 | |
| EGSLEEGRRATGLPA | 41 | Q8WXB4 | |
| RERDSAEGGEGNTGP | 1891 | Q15911 | |
| SRGREPRALGAEDTD | 386 | C9JVI0 | |
| RTGAGGDGLARPEDD | 506 | Q5R3F8 | |
| RSSGDPRDGDSVGEE | 366 | Q6NSI3 | |
| EELLDSRTPAGRGAG | 671 | Q9ULH4 | |
| GAGEEIAEALSRPGR | 1036 | O15069 |